Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
15
Number of overlapping holdings
30.0%
% of FTXH's 51 holdings also in CANC
33.3%
% of CANC's 46 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus CANC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
MERCK & CO. INC. | 7.6% | 5.6% | 5.6% |
|
REGENERON PHARMACEUTICALS | 3.5% | 5.6% | 3.5% |
|
GILEAD SCIENCES INC | 3.5% | 2.9% | 2.9% |
|
BRISTOL-MYERS SQUIBB CO | 7.4% | 2.5% | 2.5% |
|
INCYTE CORP | 1.0% | 2.4% | 1.0% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to CANC
|
PFIZER INC | 7.5% |
|
ABBVIE INC | 7.2% |
|
JOHNSON & JOHNSON | 7.0% |
|
BRISTOL-MYERS SQUIBB CO | 4.9% |
|
AMGEN INC | 3.8% |
|
CARDINAL HEALTH INC | 3.7% |
|
ELI LILLY & CO | 3.7% |
|
UNITED THERAPEUTICS CORP | 3.7% |
|
VERTEX PHARMACEUTICALS INC | 3.6% |
|
VIATRIS, INC. | 3.5% |
FTXH Underweight Relative to CANC
 |
DAIICHI SANKYO CO LTD | -4.0% |
 |
ASTRAZENECA PLC | -3.8% |
 |
NOVARTIS AG | -3.7% |
|
REVOLUTION MEDICINES, INC. | -3.1% |
 |
ARGENX SE ADR | -2.9% |
|
ILLUMINA INC | -2.9% |
|
CHUGAI PHARMACEUTICAL CO LTD | -2.7% |
|
CELLDEX THERAPEUTICS INC | -2.6% |
|
EXACT SCIENCES CORP | -2.5% |
|
DAY ONE BIOPHARMACEUTICALS, INC. | -2.1% |